Type 2 DM as initial therapy to improve glycemic control when diet & exercise alone do not provide adequate glycemic control. Type 2 DM as adjunct to diet & exercise to improve glycemic control in patients who can not be controlled with metformin or sitagliptin alone or in patients already being treated with combination of sitagliptin & metformin. As part of triple combination therapy with a sulfonylurea or with a PPARY agonist (ie, thiazolidinediones) as an adjunct to diet & exercise in patients with type 2 DM inadequately controlled with any 2 of 3 agents: Metformin, sitagliptin or a sulfonylurea alone or a PPARY agonist alone. Type 2 DM as an adjunct to diet & exercise to improve glycemic control in combination with insulin; sitagliptin & metformin.

This is not a substitute for consulting your doctor. Seek professional advice if you are experiencing any illness or symptoms.

Should be taken with food.